New York State Teachers Retirement System Increases Stake in Innospec Inc. (NASDAQ:IOSP)

New York State Teachers Retirement System increased its position in shares of Innospec Inc. (NASDAQ:IOSPFree Report) by 16.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,110 shares of the specialty chemicals company’s stock after buying an additional 2,185 shares during the period. New York State Teachers Retirement System owned about 0.06% of Innospec worth $1,862,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. PNC Financial Services Group Inc. increased its stake in shares of Innospec by 5.5% during the second quarter. PNC Financial Services Group Inc. now owns 1,735 shares of the specialty chemicals company’s stock valued at $174,000 after buying an additional 91 shares during the period. Lazard Asset Management LLC increased its stake in shares of Innospec by 8.8% during the fourth quarter. Lazard Asset Management LLC now owns 1,163 shares of the specialty chemicals company’s stock valued at $119,000 after buying an additional 94 shares during the period. Raymond James Trust N.A. increased its stake in shares of Innospec by 5.1% during the second quarter. Raymond James Trust N.A. now owns 2,429 shares of the specialty chemicals company’s stock valued at $244,000 after buying an additional 118 shares during the period. O Shaughnessy Asset Management LLC increased its stake in shares of Innospec by 4.3% during the first quarter. O Shaughnessy Asset Management LLC now owns 3,386 shares of the specialty chemicals company’s stock valued at $348,000 after buying an additional 139 shares during the period. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Innospec by 1.5% during the fourth quarter. The Manufacturers Life Insurance Company now owns 9,734 shares of the specialty chemicals company’s stock valued at $1,001,000 after buying an additional 143 shares during the period. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Innospec Trading Down 0.7 %

Shares of Innospec stock opened at $120.97 on Wednesday. The stock’s fifty day moving average price is $124.08 and its 200-day moving average price is $114.96. Innospec Inc. has a 12 month low of $91.74 and a 12 month high of $131.18. The firm has a market cap of $3.02 billion, a P/E ratio of 21.72 and a beta of 1.10.

Innospec (NASDAQ:IOSPGet Free Report) last posted its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.59 by $0.25. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The company had revenue of $494.70 million for the quarter, compared to analyst estimates of $479.47 million. During the same quarter in the previous year, the firm earned $1.20 earnings per share. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. Analysts forecast that Innospec Inc. will post 6.72 earnings per share for the current year.

Insider Buying and Selling at Innospec

In other Innospec news, SVP David B. Jones sold 2,500 shares of Innospec stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the transaction, the senior vice president now owns 9,664 shares in the company, valued at $1,215,634.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Leslie J. Parrette bought 410 shares of the business’s stock in a transaction on Thursday, February 22nd. The shares were bought at an average price of $123.96 per share, for a total transaction of $50,823.60. Following the completion of the purchase, the director now directly owns 3,620 shares of the company’s stock, valued at $448,735.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP David B. Jones sold 2,500 shares of Innospec stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $125.79, for a total value of $314,475.00. Following the completion of the transaction, the senior vice president now owns 9,664 shares in the company, valued at approximately $1,215,634.56. The disclosure for this sale can be found here. Insiders have sold 36,500 shares of company stock worth $4,532,959 over the last quarter. Insiders own 1.35% of the company’s stock.

Innospec Company Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

See Also

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.